Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Lederman

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
Virus Research|December 2, 1998
LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progressionM E Quiñones-Mateu, A Mas, T Lain de Lera, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapyG R Picchio, H Valdez, R Sabbe, et al.
Human Pathology|January 1, 1981
Toxic shock syndrome: clinicopathologic findings in a fatal caseF W Abdul-Karim, M M Lederman, J R Carter, et al.
Transfusion|October 1, 1996
Human immunodeficiency virus type 1 activation after blood transfusionP M Mudido, D Georges, D Dorazio, et al.
Blood|July 4, 2001
Survival of transfused donor white blood cells in HIV-infected recipientsM S Kruskall, T H Lee, S F Assmann, et al.
Clinical and Diagnostic Laboratory Immunology|July 17, 1998
Measurement of induced cytokines in AIDS clinical trials using whole blood: a preliminary report. ACTG Inducible Cytokines Focus Group. AIDS Clinical Trials GroupR S Wallis, H M Lederman, J Spritzler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2001
Genotypic drug resistance and cause of death in HIV-infected persons who died in 1999N K Beinker, D L Mayers, C G Lange, et al.
Journal of Clinical Microbiology|January 4, 2001
Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex diseaseD V Havlir, F J Torriani, R D Schrier, et al.
The Journal of Clinical Investigation|August 1, 1996
Activation of antigen-induced lymphocyte proliferation by interleukin-15 without the mitogenic effect of interleukin-2 that may induce human immunodeficiency virus-1 expressionA H Patki, M E Quiñones-Mateu, D Dorazio, et al.
Journal of General Internal Medicine|September 1, 1988
Prognostic factors in acquired immunodeficiency syndromeJ D Wenger, C C Whalen, M M Lederman, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
Virus Research|December 2, 1998
LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progressionM E Quiñones-Mateu, A Mas, T Lain de Lera, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapyG R Picchio, H Valdez, R Sabbe, et al.
Human Pathology|January 1, 1981
Toxic shock syndrome: clinicopathologic findings in a fatal caseF W Abdul-Karim, M M Lederman, J R Carter, et al.
Transfusion|October 1, 1996
Human immunodeficiency virus type 1 activation after blood transfusionP M Mudido, D Georges, D Dorazio, et al.
Blood|July 4, 2001
Survival of transfused donor white blood cells in HIV-infected recipientsM S Kruskall, T H Lee, S F Assmann, et al.
Clinical and Diagnostic Laboratory Immunology|July 17, 1998
Measurement of induced cytokines in AIDS clinical trials using whole blood: a preliminary report. ACTG Inducible Cytokines Focus Group. AIDS Clinical Trials GroupR S Wallis, H M Lederman, J Spritzler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2001
Genotypic drug resistance and cause of death in HIV-infected persons who died in 1999N K Beinker, D L Mayers, C G Lange, et al.
Journal of Clinical Microbiology|January 4, 2001
Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex diseaseD V Havlir, F J Torriani, R D Schrier, et al.
The Journal of Clinical Investigation|August 1, 1996
Activation of antigen-induced lymphocyte proliferation by interleukin-15 without the mitogenic effect of interleukin-2 that may induce human immunodeficiency virus-1 expressionA H Patki, M E Quiñones-Mateu, D Dorazio, et al.
Journal of General Internal Medicine|September 1, 1988
Prognostic factors in acquired immunodeficiency syndromeJ D Wenger, C C Whalen, M M Lederman, et al.
Pageof 14